CYTOSORBENTS CORPORATION Other Current Liabilities
CYTOSORBENTS CORPORATION (CTSO) had Other Current Liabilities of $965.00 thousand as of 2025-06-30, per its 10-Q filed 2025-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2025-08-07
- 2025-06-30: Other Liabilities, Current $965.00K.
- 2025-03-31: Other Liabilities, Current $796.92K.
- 2024-12-31: Other Liabilities, Current $812.00K; Other Liabilities, Current as first filed $865.51K.
- 2023-12-31: Other Liabilities, Current $991.54K.
| Period end | Other Liabilities, Current | Other Liabilities, Current as first filed |
|---|---|---|
| 2025-06-30 | $965.00K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $796.92K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $812.00K 10-Q · filed 2025-08-07 | $865.51K 10-K · filed 2025-03-31 |
| 2023-12-31 | $991.54K 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |